REQUEST A DEMO
Total
USD $0.00
« Back to previous page

China Pharmaceutical Sector Report 2020 1st Quarter

An EMIS Insights Industry Report
EMIS is an ISI Emerging Markets Group Company
Date: April 2020
Pages: 62
Available in: English
In the fourth quarter of 2019, China’s production volume of active pharmaceutical ingredients (API) declined by 12.7% y/y to 633,000 tonnes, mainly due to the environment-driven production cuts. The decline in output dragged down the sales volume of API, which dropped by 15.9% y/y to 594,200 tonnes. China’s centralised drug procurement scheme launched at the end of 2018, resulted in a notable decline in drug prices. Many producers experienced significant profit drops and some even suffered financial losses. Furthermore, there was a high pressure to limit the output of some heavily polluting API plants due to environmental concerns, which also had a negative effect on API production. In Q4 2019, the production of TCM in China reached 609,000 tonnes, inching up by 0.2% y/y.
 
 

This report provides a complete and detailed analysis of the pharmaceutical sector for China. EMIS Insights presents in-depth business intelligence in a standard format across countries and regions, providing a balanced mix between analysis and data.

What this report allows you to do:

  • Understand the key elements at play in the pharmaceutical sector in China
  • Access forecasts for growth in the sector
  • View key data on production and sales for the sector in China
  • Crystallise the forces both driving and restraining this sector in China
  • Build a complete perspective on sector trade, investment and employment
  • Understand the competitive landscape and who the major players are
  • View M&A activity and major deals
  • Gain an understanding of the regulatory environment for the sector in China
  • Build a clear picture of trends and issues for sub-sectors (western medicine, traditional Chinese medicine)

See below for a complete table of report contents:

 
 
China Pharmaceutical Sector Report 2020 1st Quarter - Page 1
Buy full report USD 495.00 Payment methods include:

DOWNLOAD A SAMPLE
Have a question?

Email us at: customerenquiries@emis.com

SEE BELOW FOR A COMPLETE TABLE OF REPORT CONTENTS:

China Pharmaceutical Sector Report 2020 1st Quarter -  Page 3
China Pharmaceutical Sector Report 2020 1st Quarter -  Page 4
China Pharmaceutical Sector Report 2020 1st Quarter -  Page 14
China Pharmaceutical Sector Report 2020 1st Quarter -  Page 19
ONCE YOU HAVE COMPLETED YOUR PURCHASE,
YOU WILL BE ABLE TO DOWNLOAD THIS REPORT IMMEDIATELY AS A PDF
If you have any questions, please contact customerenquires@emis.com
Buy full report
Need ongoing access to company, industry or country information?